Raymond James & Associates’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-109,910
| Closed | -$670K | – | 3933 |
|
|
2022
Q4 | $670K | Buy |
+109,910
| New | +$670K | ﹤0.01% | 2673 |
|
|
2021
Q1 | – | Sell |
-12,244
| Closed | -$88K | – | 3912 |
|
|
2020
Q4 | $88K | Sell |
12,244
-5,650
| -32% | -$40.6K | ﹤0.01% | 3524 |
|
|
2020
Q3 | $191K | Buy |
17,894
+1,142
| +7% | +$12.2K | ﹤0.01% | 3206 |
|
|
2020
Q2 | $211K | Buy |
16,752
+658
| +4% | +$8.29K | ﹤0.01% | 3077 |
|
|
2020
Q1 | $147K | Buy |
16,094
+1,822
| +13% | +$16.6K | ﹤0.01% | 3111 |
|
|
2019
Q4 | $199K | Sell |
14,272
-12,044
| -46% | -$168K | ﹤0.01% | 3321 |
|
|
2019
Q3 | $453K | Buy |
26,316
+14,988
| +132% | +$258K | ﹤0.01% | 2706 |
|
|
2019
Q2 | $308K | Sell |
11,328
-4,187
| -27% | -$114K | ﹤0.01% | 2982 |
|
|
2019
Q1 | $297K | Buy |
+15,515
| New | +$297K | ﹤0.01% | 2975 |
|